| Product NDC: | 28595-300 |
| Proprietary Name: | Brohist D |
| Non Proprietary Name: | Brompheniramine Maleate and Phenylephrine Hydrochloride |
| Active Ingredient(s): | 4; 10 mg/1; mg/1 & nbsp; Brompheniramine Maleate and Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 28595-300 |
| Labeler Name: | Allegis Pharmaceuticals, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120910 |
| Package NDC: | 28595-300-60 |
| Package Description: | 60 TABLET, COATED in 1 BOTTLE (28595-300-60) |
| NDC Code | 28595-300-60 |
| Proprietary Name | Brohist D |
| Package Description | 60 TABLET, COATED in 1 BOTTLE (28595-300-60) |
| Product NDC | 28595-300 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Brompheniramine Maleate and Phenylephrine Hydrochloride |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120910 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Allegis Pharmaceuticals, LLC |
| Substance Name | BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 4; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |